Robert Peter Kadlec

CIK: 0002047073

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INKT

MiNK Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

INKT
MiNK Therapeutics, Inc.
Dec 1, 2025
Award(A)
Direct
1.2K shares at avg. $11.09$14K
INKT
MiNK Therapeutics, Inc.
Sep 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3.2K shares-
INKT
MiNK Therapeutics, Inc.
Sep 2, 2025
Award(A)
Direct
975 shares at avg. $13.86$14K
INKT
MiNK Therapeutics, Inc.
Jun 2, 2025
Award(A)
Direct
1.9K shares at avg. $7.17$14K
INKT
MiNK Therapeutics, Inc.
Mar 3, 2025
Award(A)
Direct
1.5K shares at avg. $8.79$14K
INKT
MiNK Therapeutics, Inc.
Dec 1, 2024
Award(A)
Direct
12.3K shares at avg. $0.73$9K
INKT
MiNK Therapeutics, Inc.
Oct 30, 2024
Award(A)
Stock Option
Direct
41.7K shares-

		Type	Shares	Price		Ownership
Dec 1, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	1,218	$11.09	$13,508	Direct
Sep 9, 2025	INKT MiNK Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	3,225	-	-	Direct
Sep 2, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	975	$13.86	$13,514	Direct
Jun 2, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	1,883	$7.17	$13,501	Direct
Mar 3, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	1,536	$8.79	$13,501	Direct
Dec 1, 2024	INKT MiNK Therapeutics, Inc.	Award(A)	12,286	$0.73	$8,969	Direct
Oct 30, 2024	INKT MiNK Therapeutics, Inc.	Award(A) Stock Option	41,745	-	-	Direct

1-7 of 7 transactions

About Kadlec Robert Peter

Kadlec Robert Peter (SEC CIK 0002047073) files insider reports with the SEC as Director of MiNK Therapeutics, Inc. (INKT).

Signal8 holds 7 ownership filings by Kadlec Robert Peter (1 Form 3, 6 Form 4), filed between Dec 9, 2024 and Dec 3, 2025. Those filings report 7 transactions, from Oct 30, 2024 to Dec 1, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Kadlec Robert Peter's filings is in NEW YORK, NY.

Recent filings by Kadlec Robert Peter

Dec 1, 2025: Grant or award of INKT shares (Form 4, code A).
Sep 9, 2025: Grant or award of INKT derivative securities (Form 4, code A).
Sep 2, 2025: Grant or award of INKT shares (Form 4, code A).
Jun 2, 2025: Grant or award of INKT shares (Form 4, code A).
Mar 3, 2025: Grant or award of INKT shares (Form 4, code A).

Other insiders filing for MiNK Therapeutics, Inc. (INKT)

Buell Jennifer, Chief Executive Officer
WIINBERG ULF, Director
Holcomb John Bradley, Director
Behner Peter, Director
Ryan Barbara, Director
Corvese Brian, Director

How to read Form 4 transaction codes